The identification of tumor-infiltrating lymphocytes in patients with stomach cancer
Background. Stomach cancer (SC) is the 6th most common neoplasm among cancers (1 033 701 cases; 5.7%) and the 3rd most deadly cancer worldwide for men and women (782 685 deaths, 8.2%). SC therapy is a complex treatment associated with surgery, adjuvant chemotherapy, targeted therapy and immunotherap...
Enregistré dans:
Auteurs principaux: | Gulnoz G. Khakimova, Yana A. Bozhchenko, Tatyana N. Zabotina, Alexey A. Tryakin |
---|---|
Format: | article |
Langue: | RU |
Publié: |
IP Habib O.N.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/757ada350e4c42cdb0eb49a48a86d7a8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II–III colorectal cancer
par: Chih-Yang Huang, et autres
Publié: (2018) -
Nomogram to Predict Tumor-Infiltrating Lymphocytes in Breast Cancer Patients
par: Jikun Feng, et autres
Publié: (2021) -
The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer
par: Laura García-Estevez, et autres
Publié: (2021) -
Gradual Histopathologic Changes During Development of Colorectal Cancer
par: Vahid Nejati, et autres
Publié: (2019) -
The effect of local immunity on gastric cancer prognosis
par: Gulnoz G. Khakimova, et autres
Publié: (2020)